Understanding Glaucoma Risk and Tailored Treatments
Official title: Understanding glaucoma risk and assessment of precision therapies: A study of mitochondria and oxidative stress in human trabecular meshwork
Funded at Washington University · NIH-11131251 · Data updated 2026-11-12
This work explores why some people develop glaucoma earlier or more severely, focusing on how cell damage in the eye contributes to this common cause of blindness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 30, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $541,880 |
| NIH project number | 5R01EY034529-03 |
| Project ID | NIH-11131251 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with glaucoma, particularly those with severe forms, or individuals at higher risk for developing the condition, are the ultimate beneficiaries of this foundational research.
✕Less likely to help
Patients whose glaucoma is not primarily driven by oxidative stress or mitochondrial issues may not directly benefit from treatments specifically developed through this research.
What this research studies
Glaucoma is a leading cause of blindness, and we know that some individuals develop it earlier or more severely due to various factors. This project aims to understand why certain cells in the eye, called trabecular meshwork cells, become damaged, leading to increased eye pressure. We believe this damage is linked to differences in how these cells process oxygen, which can vary based on a person's genetic makeup. By studying eye fluid from patients with severe glaucoma and comparing eye cells from healthy and affected donors, we hope to uncover the root causes of this oxidative damage. This deeper understanding is crucial for developing more targeted and effective treatments.
Why it matters
Potential benefit: If successful, this work could lead to new, more precise treatments for glaucoma by targeting the specific causes of cell damage in the eye.
How similar studies have gone: While previous studies have strongly linked oxidative damage to glaucoma, this project explores the specific causes of this damage and its connection to oxygen metabolism in a novel way.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Siegfried, Carla J — Washington University
- Study coordinator: Siegfried, Carla J
Related research
Other NIH-funded projects on the same topics.
-
Understanding glaucoma risk and mitochondria in eye cells
A study to understand why people develop glaucoma by looking at how mitochondria and oxidative damage in eye drainage cells might contribute to high eye pressure.
-
Investigating the role of mitochondria and oxidative stress in glaucoma risk and treatment.
This study is looking at how damage from oxygen affects a part of the eye that helps control pressure and can lead to glaucoma, with the goal of figuring out why some people are more likely to get this condition, so we can create better treatments just for them.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Comparing tube positions in glaucoma implants to protect corneal cells
This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.
-
Automated topographic test for glaucoma detection and progression
A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.
-
How vitamin B12 helps the gum-disease bacterium survive
Learning how vitamin B12 helps the bacteria that cause gum disease survive and become more harmful for people with periodontitis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.